Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-03-20 | Reverse | 1:15 |
Outset Medical, Inc. develops the Tablo Hemodialysis System, a compact, connected device for acute and home dialysis that integrates water purification and on-demand dialysate production.

The Tablo Hemodialysis System is a compact, user-friendly, all-in-one device that simplifies dialysis by integrating water purification and dialysate production for use in hospitals and homes.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product | $20.56M | $19.87M ▼ | $18.55M ▼ | $21.91M ▲ |
![]() | Consumables Product | $12.22M | $13.5M ▲ | $13.18M ▼ | $12.42M ▼ |
![]() | Service And Other Revenue | $8.87M | $9M ▲ | $9.31M ▲ | $9.73M ▲ |
![]() | Consoles Product | $8.34M | $6.37M ▼ | $5.37M ▼ | $9.49M ▲ |
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
SI | $21.16 | COMPARE |
VMD | $8.82 | COMPARE |
TNYA | $0.69 | COMPARE |
INGN | $5.50 | COMPARE |
HSDT | $2.34 | COMPARE |
QTRX | $2.64 | COMPARE |
NNOX | $0.83 | COMPARE |
SNWV | $4.67 | COMPARE |